Artemisinin News and Research

RSS
Artemisinin is a drug used to treat multi-drug resistant strains of falciparum malaria. The compound (a sesquiterpene lactone) is isolated from the plant Artemisia annua. Not all plants of this species contain artemisinin.
Laos malaria outbreak in 2020–21 likely caused by multidrug-resistant strains of P. falciparum

Laos malaria outbreak in 2020–21 likely caused by multidrug-resistant strains of P. falciparum

Meta-analysis informs a change to treatment guidelines for uncomplicated malaria in the first trimester of pregnancy

Meta-analysis informs a change to treatment guidelines for uncomplicated malaria in the first trimester of pregnancy

Researchers discover new antiviral compounds derived from two Korean native plants

Researchers discover new antiviral compounds derived from two Korean native plants

Scientists create a mathematical model to predict genetic resistance to antimalarial drugs

Scientists create a mathematical model to predict genetic resistance to antimalarial drugs

The effect of Artemisia annua hot water extracts against the SARS-CoV-2 Omicron variant

The effect of Artemisia annua hot water extracts against the SARS-CoV-2 Omicron variant

Researchers evaluate artemisinin for COVID-19 management

Researchers evaluate artemisinin for COVID-19 management

Well-established group of antimalarials unlikely to be affected by resistance, study shows

Well-established group of antimalarials unlikely to be affected by resistance, study shows

World Malaria Day 2022: How the knockdown of P. falciparum RAP01 and RAP21 proteins could lead to novel antimalarial therapeutics

World Malaria Day 2022: How the knockdown of P. falciparum RAP01 and RAP21 proteins could lead to novel antimalarial therapeutics

Tumor cells’ 'ferroaddiction' can be exploited to deliver powerful anticancer drugs

Tumor cells’ 'ferroaddiction' can be exploited to deliver powerful anticancer drugs

IPD pooled analysis quantifies the underlying hematological response following malaria infection

IPD pooled analysis quantifies the underlying hematological response following malaria infection

Outcomes of phase 3 clinical trial of CVO PLUS CURATIF capsules for COVID-19 treatment

Outcomes of phase 3 clinical trial of CVO PLUS CURATIF capsules for COVID-19 treatment

New study provides a mutational analysis of SARS-CoV-2

New study provides a mutational analysis of SARS-CoV-2

Study uncovers mechanism for insensitivity to key antimalarial drug in new pathogen variant

Study uncovers mechanism for insensitivity to key antimalarial drug in new pathogen variant

Study assesses whether medicinal mushrooms and Chinese herbs can help treat COVID-19

Study assesses whether medicinal mushrooms and Chinese herbs can help treat COVID-19

Malaria: An Interview with the World Health Organization

Malaria: An Interview with the World Health Organization

Can targeting autophagy become a new approach to COVID-19 treatment?

Can targeting autophagy become a new approach to COVID-19 treatment?

Artemisia plant extract prevents SARS-CoV-2 replication in vitro

Artemisia plant extract prevents SARS-CoV-2 replication in vitro

Study looks at potent phytocompounds from Himalayan herbs to treat COVID-19

Study looks at potent phytocompounds from Himalayan herbs to treat COVID-19

China earns a malaria-free certification from WHO

China earns a malaria-free certification from WHO

Study proves effectiveness of Artemisia annua against SARS-CoV-2 in vitro

Study proves effectiveness of Artemisia annua against SARS-CoV-2 in vitro